GENE ONLINE|News &
Opinion
Blog

Amyotrophic Lateral Sclerosis
FDA Grants Biogen’s Ultra-Rare ALS Med Accelerated Approval
2023-04-26
Biogen’s Tofersen May Show Clinical Benefit in ALS Patients with Rare SOD1 Mutations
2023-03-21
Harvard’s Soft Robotic Wearable Device Helps ALS Patients Regain Arm Mobility
2023-02-09
Repairing Genetic Mutations in Neurological Diseases with RNA Targeting Strategy
2022-11-25
Biogen’s ALS Drug Fails to Attain Primary Endpoint but Offers Hope With Secondary Outcomes
2021-10-18
Setting its Sights on Neurological Disorders, CRISPR Therapeutics Turns to an AAV Startup That Just Emerged Out of Stealth
2021-06-16
Lilly to Expand Foothold in the Billion-Dollar Autoimmune and Inflammatory Disease Market with this New Collaboration
2021-02-20
Brainstorm’s Stem Cell Therapy Flunks Phase 3 ALS Trial
2020-11-20
Scribe, Biogen Partner to Combat ALS using Nobel Prize-Winning CRISPR Technology
2020-10-08
R&D
Altering the Treatment Landscape of Neurodegenerative Diseases Using Antisense Oligonucleotides (ASOs)
2020-08-17
R&D
Merck and Yumanity Sign $500 Million Deal to Develop ALS and FTLD Treatments
2020-06-26
LATEST
Preventive Medicine for Neurodegeneration on the Rise: New Breakthrough in Routine Blood Testing for Alzheimer’s Disease
2024-05-20
Discrimination Leads to Rapid Aging, Science Shows the Detrimental Effects of this Act
2024-05-17
A New Study has Linked Treatment Resistant Depression to Body Mass Index
2024-05-16
AI Reveals Sex-Related Brain Differences and Precision Medicine Potential
2024-05-16
The EU Sustainability Directive’s Influence on Pharmaceutical Supply Chains
2024-05-15
New UC Berkeley Study Challenges Traditional Views on Lactate and Carbohydrate Metabolism
2024-05-15
First Person to Receive Transplanted Pig Kidney has Died
2024-05-13
EVENT
Scroll to Top